Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 3
2022 10
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
A Community-Based Therapeutic Education Programme for People with Alcohol Use Disorder in France: A Qualitative Study (ETHER).
Costa M, Barré T, Antwerpes S, Coste M, Bureau M, Ramier C, Maradan G, Riccobono-Soulier O, Vassas-Goyard S, Casanova D, Carrieri P. Costa M, et al. Among authors: bureau m. Int J Environ Res Public Health. 2022 Jul 28;19(15):9228. doi: 10.3390/ijerph19159228. Int J Environ Res Public Health. 2022. PMID: 35954605 Free PMC article.
Cannabis Use Is Inversely Associated with Overweight and Obesity in Hepatitis B Virus-Infected Patients (ANRS CO22 Hepather Cohort).
Barré T, Pol S, Ramier C, Di Beo V, Carrat F, Bureau M, Bourlière M, Dorival C, Serfaty L, Asselah T, Boursier J, Marcellin F, Carrieri P, Fontaine H, Protopopescu C; ANRS/AFEF Hepather Study Group. Barré T, et al. Among authors: bureau m. Cannabis Cannabinoid Res. 2022 Oct;7(5):677-689. doi: 10.1089/can.2021.0094. Epub 2021 Oct 13. Cannabis Cannabinoid Res. 2022. PMID: 34648718 Free PMC article.
Cannabis Use Is Inversely Associated with Metabolic Disorders in Hepatitis C-Infected Patients (ANRS CO22 Hepather Cohort).
Barré T, Bourlière M, Ramier C, Carrat F, Di Beo V, Protopopescu C, Marcellin F, Bureau M, Cagnot C, Dorival C, Zoulim F, Zucman-Rossi J, Duclos-Vallée JC, Fontaine H, Carrieri P, The Anrs/Afef Hepather Study Group. Barré T, et al. Among authors: bureau m. J Clin Med. 2022 Oct 18;11(20):6135. doi: 10.3390/jcm11206135. J Clin Med. 2022. PMID: 36294456 Free PMC article.
Late presentation for HCV care: Time to target people with diabetes and/or hazardous alcohol use (ANRS CO22 HEPATHER cohort).
Santos M, Protopopescu C, Delarocque-Astagneau E, Bourlière M, Petrov-Sanchez V, Di Beo V, Larrey D, Baudoin M, Dorival C, Bureau M, Fontaine H, Carrat F, Marcellin F, Pol S, Carrieri P; ANRS CO22 HEPATHER study group. Santos M, et al. Among authors: bureau m. Liver Int. 2022 Jan;42(1):38-49. doi: 10.1111/liv.15056. Epub 2021 Sep 18. Liver Int. 2022. PMID: 34520614
Metabolic Disorders in Patients with Chronic Hepatitis B Virus Infection: Coffee as a Panacea? (ANRS CO22 Hepather Cohort).
Barré T, Fontaine H, Pol S, Ramier C, Di Beo V, Protopopescu C, Marcellin F, Bureau M, Bourlière M, Dorival C, Petrov-Sanchez V, Asselah T, Delarocque-Astagneau E, Larrey D, Duclos-Vallée JC, Carrat F, Carrieri P, On Behalf Of The Anrs/Afef Hepather Study Group. Barré T, et al. Among authors: bureau m. Antioxidants (Basel). 2022 Feb 14;11(2):379. doi: 10.3390/antiox11020379. Antioxidants (Basel). 2022. PMID: 35204261 Free PMC article.
Evaluation of a novel therapeutic education programme for people with alcohol use disorder in France: a mixed-methods intervention study protocol (ETHER).
Antwerpes S, Costa M, Coste M, Bureau M, Maradan G, Cutarella C, Leloutre J, Riccobono-Soulier O, Hedoire S, Frot E, Vernier F, Vassas-Goyard S, Barré T, Casanova D, Carrieri P. Antwerpes S, et al. Among authors: bureau m. Harm Reduct J. 2022 Jan 10;19(1):2. doi: 10.1186/s12954-021-00587-0. Harm Reduct J. 2022. PMID: 35012570 Free PMC article.
A novel community-based therapeutic education program for reducing alcohol-related harms and stigma in people with alcohol use disorders: A quasi-experimental study (ETHER study).
Barré T, Ramier C, Antwerpes S, Costa M, Bureau M, Maradan G, Di Beo V, Cutarella C, Leloutre J, Riccobono-Soulier O, Hedoire S, Frot E, Vernier F, Vassas-Goyard S, Dufort S, Protopopescu C, Marcellin F, Casanova D, Coste M, Carrieri P. Barré T, et al. Among authors: bureau m. Drug Alcohol Rev. 2023 Mar;42(3):664-679. doi: 10.1111/dar.13605. Epub 2023 Jan 31. Drug Alcohol Rev. 2023. PMID: 36721903
13 results